<bill session="115" type="s" number="3770" updated="2019-10-18T16:08:29Z">
  <state datetime="2018-12-18">REFERRED</state>
  <status>
    <introduced datetime="2018-12-18"/>
  </status>
  <introduced datetime="2018-12-18"/>
  <titles>
    <title type="official" as="introduced">A bill to amend title XI of the Social Security Act to expand the scope of transparency reporting requirements related to the ownership or investment interests of health care providers and others, and to increase the penalties associated with violating such requirements.</title>
    <title type="short" as="introduced">Medicaid Drug Decisions Transparency Act</title>
    <title type="short" as="introduced">Medicaid Drug Decisions Transparency Act</title>
    <title type="display">Medicaid Drug Decisions Transparency Act</title>
  </titles>
  <sponsor bioguide_id="B001288"/>
  <cosponsors/>
  <actions>
    <action datetime="2018-12-18">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-12-18" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2018-12-18T05:00:00Z" status="Introduced in Senate">Medicaid Drug Decisions Transparency Act

This bill expands Medicaid and Medicare reporting requirements related to the transparency of physician ownership or investment interests to include pharmacists and individuals with authority over Medicaid formularies, and also increases civil penalties for violations.</summary>
  <committee-reports/>
</bill>
